PFKFB4 and neuroblastoma: The worst survival prognosis could be observed for the patients with the dominant PFKFB3 expression (G3 group), which clearly indicates that low expression of PFKFB4, and high expression of PFKFB3 at the same time has a negative impact on the survival of neuroblastoma patients.